Hsu HS - Search Results

1

CBL is frequently altered in lung cancers: its relationship to mutations in MET and EGFR tyrosine kinases.

Tan YH, Krishnaswamy S, Nandi S, Kanteti R, Vora S, Onel K, Hasina R, Lo FY, El-Hashani E, Cervantes G, Robinson M, Hsu HS, Kales SC, Lipkowitz S, Karrison T, Sattler M, Vokes EE, Wang YC, Salgia R. Tan YH, et al. Among authors: hsu hs. PLoS One. 2010 Jan 29;5(1):e8972. doi: 10.1371/journal.pone.0008972. PLoS One. 2010. PMID: 20126411 Free PMC article.

2

5' cytosine-phospho-guanine island methylation is responsible for p14ARF inactivation and inversely correlates with p53 overexpression in resected non-small cell lung cancer.

Hsu HS, Wang YC, Tseng RC, Chang JW, Chen JT, Shih CM, Chen CY, Wang YC. Hsu HS, et al. Clin Cancer Res. 2004 Jul 15;10(14):4734-41. doi: 10.1158/1078-0432.CCR-03-0704. Clin Cancer Res. 2004. PMID: 15269146

3

EGFR mutations in malignant pleural effusion of non-small cell lung cancer: a case report.

Huang MJ, Lim KH, Tzen CY, Hsu HS, Yen Y, Huang BS. Huang MJ, et al. Among authors: hsu hs. Lung Cancer. 2005 Sep;49(3):413-5. doi: 10.1016/j.lungcan.2005.02.016. Lung Cancer. 2005. PMID: 15913841

4

Promoter hypermethylation is the predominant mechanism in hMLH1 and hMSH2 deregulation and is a poor prognostic factor in nonsmoking lung cancer.

Hsu HS, Wen CK, Tang YA, Lin RK, Li WY, Hsu WH, Wang YC. Hsu HS, et al. Among authors: hsu wh. Clin Cancer Res. 2005 Aug 1;11(15):5410-6. doi: 10.1158/1078-0432.CCR-05-0601. Clin Cancer Res. 2005. PMID: 16061855

5

Reduced acetylated histone H4 is associated with promoter methylation of the fragile histidine triad gene in resected esophageal squamous cell carcinoma.

Tzao C, Sun GH, Tung HJ, Hsu HS, Hsu WH, Wang YC, Cheng YL, Lee SC. Tzao C, et al. Among authors: hsu hs, hsu wh. Ann Thorac Surg. 2006 Aug;82(2):396-401; discussion 401. doi: 10.1016/j.athoracsur.2006.03.066. Ann Thorac Surg. 2006. PMID: 16863736

6

Molecular diagnostic markers for lung cancer in sputum and plasma.

Wang YC, Hsu HS, Chen TP, Chen JT. Wang YC, et al. Among authors: hsu hs. Ann N Y Acad Sci. 2006 Sep;1075:179-84. doi: 10.1196/annals.1368.024. Ann N Y Acad Sci. 2006. PMID: 17108209

7

Alteration of DNA methyltransferases contributes to 5'CpG methylation and poor prognosis in lung cancer.

Lin RK, Hsu HS, Chang JW, Chen CY, Chen JT, Wang YC. Lin RK, et al. Among authors: hsu hs. Lung Cancer. 2007 Feb;55(2):205-13. doi: 10.1016/j.lungcan.2006.10.022. Epub 2006 Nov 30. Lung Cancer. 2007. PMID: 17140695

8

Epigenetic inactivation of the chromosomal stability control genes BRCA1, BRCA2, and XRCC5 in non-small cell lung cancer.

Lee MN, Tseng RC, Hsu HS, Chen JY, Tzao C, Ho WL, Wang YC. Lee MN, et al. Among authors: hsu hs. Clin Cancer Res. 2007 Feb 1;13(3):832-8. doi: 10.1158/1078-0432.CCR-05-2694. Clin Cancer Res. 2007. PMID: 17289874

9

Polymorphism in the hMSH2 gene (gISV12-6T > C) is a prognostic factor in non-small cell lung cancer.

Hsu HS, Lee IH, Hsu WH, Kao WT, Wang YC. Hsu HS, et al. Among authors: hsu wh. Lung Cancer. 2007 Oct;58(1):123-30. doi: 10.1016/j.lungcan.2007.04.018. Epub 2007 Jun 12. Lung Cancer. 2007. PMID: 17566596

10

Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma.

Hsu HS, Chen TP, Hung CH, Wen CK, Lin RK, Lee HC, Wang YC. Hsu HS, et al. Cancer. 2007 Nov 1;110(9):2019-26. doi: 10.1002/cncr.23001. Cancer. 2007. PMID: 17876837 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

338 results

Search Page

Filters